TNDM

TNDM

USD

Tandem Diabetes Care Inc. Common Stock

$15.210+0.980 (6.887%)

即時價格

Healthcare
醫療器材
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$14.230

最高

$15.355

最低

$14.140

交易量

0.77M

公司基本面

市值

1.0B

行業

醫療器材

國家

United States

交易統計

平均交易量

2.13M

交易所

NGM

貨幣

USD

52週範圍

最低 $9.98當前 $15.210最高 $38.28

相關新聞

BusinessWire

Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

Certification affirms Tandem's company-wide commitment to cybersecurity, data protection, and operational integrity Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company,

查看更多
Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

查看更多
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
BusinessWire

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Stifel 2025

查看更多
Tandem Diabetes Care Announces Upcoming Conference Presentations
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

查看更多
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors ...

查看更多
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
PR Newswire

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem...

Analyst Upgrades

Stifel Reinstates Hold on Tandem Diabetes Care, Announces $15 Price Target

Stifel analyst Jonathan Block reinstates Tandem Diabetes Care with a Hold and announces $15 price target.